Safety and Immunogenicity Among Adults of Fluzone(R), Influenza Virus Vaccines 2012-2013 Formulation (Intradermal and Intramuscular Route)

Trial Profile

Safety and Immunogenicity Among Adults of Fluzone(R), Influenza Virus Vaccines 2012-2013 Formulation (Intradermal and Intramuscular Route)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2013

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 28 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top